Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.

This is the first large, robust study of the efficacy of IV NAC in respiratory diseases with abnormal mucus secretion. It provides new evidence for IV NAC administration in this indication in clinical situations where the IV route is preferred.